TY  - JOUR
AU  - Sicras-Mainar, Antoni
AU  - Morillo-Verdugo, Ramón
PY  - 2022
DO  - 10.20882/adicciones.1551
SN  - 0214-4840
UR  - http://hdl.handle.net/10668/21750
T2  - Adicciones
AB  - Our objective was to determine potential drug interactions (DI) between pangenotypic direct-acting antivirals (pDAA) and concomitant central nervous system (CNS) medication in patients with chronic hepatitis C virus (HCV). Transversal design. Patients...
LA  - en
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Female
KW  - Sofosbuvir
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - Antiviral Agents
KW  - Hepatitis C
KW  - Central Nervous System Agents
TI  - Concomitant use of direct-acting antivirals (DAA) and central nervous system drugs in patients with hepatitis C virus infection.
T2  - Uso concomitante de antivirales de acción directa (AAD) y fármacos con acción sobre el sistema nervioso central: Consideraciones en el perfil actual del paciente con hepatitis C.
TY  - research article
VL  - 34
ER  -